Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MegaWatt Metals Provides Overview of Canada’s Uranium Mining Market & Significant Undiscovered Deposits
-
HF Fund: Auction results for LSS150434
-
Acreage Enters into US$10MM Private Placement
-
WOOFi Launches 395,000 ARB Incentives for its Users
-
TRYX to Showcase New Products at Computex 2024 in Taipei
-
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
-
Alaska Energy Metals Closes Option to Acquire the Bambino Nickel – Copper Property and Commences Exploration Programs on Its Quebec Properties
-
Pre-Commissioning of Fumed Silica Reactor Pilot Plant Underway
-
Fireweed Launches Largest Regional Exploration Campaign at Macpass
-
Ocular Therapeutix® to Host Investor Day on June 13, 2024
-
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference
-
Ollie’s Bargain Outlet Reports First Quarter Fiscal 2024 Financial Results
-
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
-
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offshore Construction Contractor
-
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
-
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference
-
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Telix Announces Launch of Proposed Initial Public Offering in the United States
-
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leadership Succession
-
Fortuna Announces Offering of Convertible Senior Notes
-
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
-
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
-
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
-
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, fo
-
SummerSeries in Trillium Park Returns at Ontario Place
-
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AutoZone Vendor Summit Recognizes Contributions of Top Suppliers
-
Lifeist Sells Australian Vapes
-
West Red Lake Gold Outlines 2024 Madsen Mine Plans
-
Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associate
-
Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress 2024
-
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
GXO Releases 2023 ESG Impact Report
-
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Instreamatic Announces New Opportunities for Brands to Access Professional Union Talent for Highly Personalized Ads
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade from B to B+
-
Lantronix IoT Solution Enables Digital Retail Shelf Signage Solution for HY-LINE Group
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade from B to B+
-
SPOD Lithium Amends Property Option Agreements and Appoints a New Director
-
ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024
-
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
-
Amplify ETFs Earns Four Nominations for With Intelligence Mutual Fund and ETF Awards
-
Mesa Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
-
PyroGenesis Clears Final Requirement to Becoming Approved Titanium Powder Supplier to Global Aerospace OEM Client
-
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Cibus to Participate in Upcoming June Investor Events
